Recent Finacing
Recent Raise
Ratio Therapeutics, Boston-based, develops targeted radiotherapeutics and diagnostics for solid tumors using proprietary Trillium and Macropa platforms for imaging and discovery, collaborating with Bayer, Lantheus, and Merck.
